A new study published in JAMA has raised concerns about the safety of certain blood pressure medications for people with ...

Warfarin was associated with more risk than apixaban (Eliquis; 55.38 vs 21.42 per 1,000 person-years, HR 2.60, 95% CI ...

Our easy-to-read patient fact sheet compares and contrasts sinus arrhythmia vs AFib (atrial fibrillation) symptoms.

The OCEANIC-AF trial has raised concerns about factor XI inhibitors. Should physicians still bet on this class of ...

A study from the University of Birmingham and German researchers has found that using anabolic steroids could increase the ...

When an older adult with atrial fibrillation, or Afib, stops taking an anticoagulant, it raises their risk of stroke or heart attack more than risks of bleeding, according to a new report published ...

Kathy Davis of Canonsburg underwent heart surgery, but complications left her with right heart failure, a condition where the ...

In a randomized controlled trial in individuals with persistent atrial fibrillation, an individualized ablation procedure, in which areas with abnormal electrophysiological characteristics—as ...

A software robot has proved to be faster than doctors at detecting side effects during a drug treatment for cardiac ...

Milestone’s NDA for CARDAMYST is currently under review at the FDA with a Prescription Drug User Fee Act (PDUFA) target date of March 27, 2025. The Company continues to advance commercial preparations ...

A new study suggests that the benefits of prescribing anticoagulation drugs to certain older people outweigh the potential risks.

however new research from the University of Bath – funded by the Dunhill Medical Trust – suggests that for patients with the common heart condition atrial fibrillation (AF), the health risks of not ...